MYC rearrangements in DLBCL can be partnered with IGH but, compared with Burkitt lymphoma, are more frequently partnered with the IGL or to non-IG genes such as BCL6, BCL11A, PAX5 or ICAROS49 [84]. This evidence concerns the gene BCL11A and Burkitt lymphoma.